Login

Matt Brown, CFO of Livetiles Ltd (ASX: LVT), discussed with Satori Fund's Founder Dan Niles about energy prices being a significant concern. 00:10:00

Share On Facebook Share On Twitter

LiveTiles is managed by CEO David Vander.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
provides seed capital and regulatory support to entrepreneurs solving challenges|Clara Brenner,Co-Founder and Managing Partner,Urban Innovation Fund
00:10:00
Liv Garfield: Leading with Authenticity and Navigating Career Success from Cambridge to Severn Trent | Liv Garfield, Managing Director ,Severn Trent PLC.
00:10:00
Base Resources: Leveraging Success in Mineral Sands Production and Expansion
00:10:00
Trends, Ideas and Innovations in Venture Capital|Jomayra Herrera,Partner,Reach Capital
00:10:00
Debating World War II: Perspectives on its Necessity and Consequences|Victor Davis Hanson
00:00:00
e-Therapeutics PLC using its drug discovery platform - Jonny Wray, CTO, E-Therapeutics PLC
00:00:00
Imugene doses first patient in intravenous monotherapy arm of Phase 1 clinical trial - Leslie Chong | CEO & Managing Director, Imugene Ltd
00:10:00
Bunker Hill Mining: Restoring an American Icon
00:10:00
Xspray Pharma CEO Presents at Naventus Life Science Summit 2021 | PER ANDERSSON , CEO OF XSPRAY PHARMA AB
00:10:00
Prospects for the Revival of ATIC's IT Business in the Year RI Changes President | Harry Surjanto, CEO, Anabatic Technologies Tbk PTATIC:JKT
00:10:00
Market Access: Embracing Innovation and Work-Life Balance in Electronic Trading
00:10:00
Revolutionizing Aerial Application with AgNav's Precision GPS Guidance Systems.

© 2017 - Neuhu+